The reserarchers found that a weekly dose of semaglutide was effective at treating Metabolic Dysfunction-Associated ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according ...

A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...

Among patients with hepatocellular carcinoma, MAFLD was not an independent predictor for overall survival or progression-free ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The international study led by a Virginia Commonwealth University researcher ...

Cedars-Sinai investigators have discovered a signaling interaction between two proteins in cells that controls fat ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

Dr Saurabh Sethi, a gastroenterologist, has gone viral on TikTok a number of times for his medical advice. Now he's shared ...

Curcumin, the active compound in turmeric, may help protect against esophageal damage caused by GERD. It has a wide range of ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...